Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Short-term Investments: 2012-2018

  • Cumberland Pharmaceuticals' Short-term Investments rose 77.44% to $8.3 million in Q4 2018 from the same period last year, while for Dec 2018 it was $8.3 million, marking a year-over-year increase of 77.44%. This contributed to the annual value of $8.3 million for FY2018, which is 77.44% up from last year.
  • Cumberland Pharmaceuticals' Short-term Investments amounted to $8.3 million in Q4 2018, which was up 77.44% from $4.7 million recorded in Q4 2017.
  • Cumberland Pharmaceuticals' Short-term Investments' 5-year high stood at $15.6 million during Q4 2016, with a 5-year trough of $4.7 million in Q4 2017.
  • Moreover, its 3-year median value for Short-term Investments was $8.3 million (2018), whereas its average is $9.5 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Short-term Investments tumbled by 70.09% in 2017 and then skyrocketed by 77.44% in 2018.
  • Over the past 5 years, Cumberland Pharmaceuticals' Short-term Investments (Quarterly) stood at $14.8 million in 2014, then fell by 1.87% to $14.6 million in 2015, then grew by 7.26% to $15.6 million in 2016, then crashed by 70.09% to $4.7 million in 2017, then spiked by 77.44% to $8.3 million in 2018.
  • Its Short-term Investments stands at $8.3 million for Q4 2018, versus $4.7 million for Q4 2017 and $15.6 million for Q4 2016.